01904cam a22005298i 45000010008000000030006000080050017000140060019000310070007000500080041000570100017000980200034001150200031001490200025001800200022002050200030002270200027002570200026002840350017003100390012003270400033003390420008003720500010003800600011003900820014004010900025004151000029004402450078004692640077005473000023006243360021006473370023006683380032006915040051007235060060007745880103008345960007009376500024009446500022009686500019009906500019010096500033010288560104010619490018011659260108011837580083012916797173OCoLC20150130120619.0m     o  d        cr |||140721s2015    enk     ob    001 0 eng    a  2014028711  a9781118912065qelectronic bk.  a1118912063qelectronic bk.  a9781118912041 (ePub)  a1118912047 (ePub)  a9781118912058 (Adobe PDF)  a1118912055 (Adobe PDF)  z9781118912072 (cloth)  aocn884440160  aexclude  aDLCbengerdacDLCdDG1dAEU  apcc10aRM30010aQV 74800a615.1223  aInternet AccessbAEU1 aCavalla, David,eauthor.10aOff-label prescribing :bjustifying unapproved medicine /cDavid Cavalla. 1aChichester, West Sussex ;aHoboken, NJ :bJohn Wiley & Sons Inc.,c2015.  a1 online resource.  atext2rdacontent  acomputer2rdamedia  aonline resource2rdacarrier  aIncludes bibliographical references and index.  aAccess restricted to authorized users and institutions.  aDescription based on print version record and CIP data provided by publisher; resource not viewed.  a44 0aDrugsxPrescribing. 0aDrug development. 2aOff-Label Use. 2aDrug Approval. 2aPharmaceutical Preparations.403University of Alberta Accessuhttp://dx.doi.org/10.1002/9781118912065z(Unlimited Concurrent Users)  hUAINzWILEYOL  aInternet AccesswLCc1i6797173-1001lINTERNETmUAINTERNETrYsYtE-RESOURCEu2/3/2015xE-BOOKzWILEYOL01ahttp://id.loc.gov/authorities/names/nb97036524bhttp://viaf.org/viaf/116793093